Abstract

In the early stages of the COVID-19 global pandemic, caused by the SARS-CoV-2 virus, low- and middle-income countries (LMICs) appeared to be experiencing lower morbidity and mortality rates than high-income countries, particularly the United States. Various suggestions put forward to account for this included the possibility that LMICs might be experiencing off-target benefits of infant vaccination with BCG, intended primarily to protect against tuberculosis. A number of ecologic epidemiological studies that considered COVID-19 morbidity and mortality rates across countries appeared to support this suggestion. Ecologic studies, however, are primarily hypothesis-generating, given their well-known limitations in extrapolating to the individual-person level. The present study, which employed anonymized records of U.S. Military Veterans treated by the Department of Veterans Affairs was principally a case-control study of COVID-19 infections with a retrospective cohort study of mortality nested within the infections. Controls were a random sample of Veterans not recorded as having had COVID-19. There were 263,039 controls and 167,664 COVID-19 cases, of whom 5,016 died. The combination of country and year of birth was used as a surrogate for infant BCG vaccination. The study did not support the hypothesis that BCG in infancy was protective against COVID-19. The odds ratio for infection was 1.07 (95% confidence interval [CI]: 1.03, 1.11) and the risk ratio for mortality among the COVID-19 cases was 0.86 (95% CI: 0.63, 1.18). The potential for non-differential exposure misclassification was a concern, possibly biasing measures of association toward the null value.

MeSH

Sars-Cov-2, Mortality, Military Personnel, Parturition, Suggestion, Vaccines, Case-Control Studies, Income, Vaccination, Covid-19, Odds Ratio, Veterans, Morbidity, Infections, Infant

Cited by

• Effectiveness of Bacille Calmette-Guerin vaccination policies in reducing infection and mortality of COVID-19: a systematic review. Glob Health Res Policy, 2022
• BCG Vaccination Potentially Modulates the Transcriptome of Infant CD4 T Cells in Addition to Age-Dependent Immune Ontogeny-Associated Changes. Vaccines (Basel), 2025
• Predictors of parental acceptance to live attenuated influenza vaccine for children. Hum Vaccin Immunother, 2024
• Spurious early ecological association suggesting BCG vaccination effectiveness for COVID-19. PLoS One, 2022
• The Natural Effect of BCG Vaccination on COVID-19: The Debate Continues. Front Immunol, 2022
• The pathophysiological mechanisms of COVID-19 and host immunity, with emphasis on the dysbiosis of the lung and gut microbiomes and pregnancy. Respir Investig, 2022
• BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents. Int Immunopharmacol, 2022
• BCG and SARS-CoV-2-What Have We Learned? Vaccines (Basel), 2022
• Understanding Kids and COVID. Proc Natl Acad Sci U S A, 2022
• Effect of BCG on Respiratory Complications Caused by COVID-19: A Scoping Review. Int J Gen Med, 2023